Cargando…
High‐Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases
Progress in development of prognostic and therapeutic options for the rare cholestatic liver diseases, primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), is hampered by limited knowledge of their pathogeneses. In particular, the potential role of hepatotoxic and/or metabolis...
Autores principales: | Walker, Douglas I., Juran, Brian D., Cheung, Angela C., Schlicht, Erik M., Liang, Yongliang, Niedzwiecki, Megan, LaRusso, Nicholas F., Gores, Gregory J., Jones, Dean P., Miller, Gary W., Lazaridis, Konstantinos N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035559/ https://www.ncbi.nlm.nih.gov/pubmed/34825528 http://dx.doi.org/10.1002/hep4.1871 |
Ejemplares similares
-
DNA methylation profile of liver tissue in end-stage cholestatic liver disease
por: Cheung, Angela C, et al.
Publicado: (2022) -
The Exposome Paradigm in Human Health: Lessons from the Emory Exposome Summer Course
por: Niedzwiecki, Megan M., et al.
Publicado: (2017) -
A scalable workflow to characterize the human exposome
por: Hu, Xin, et al.
Publicado: (2021) -
Genome-wide resolution peripheral blood methylome profiling reveals signatures for cholestatic liver disease
por: Moore, Raymond M, et al.
Publicado: (2020) -
Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers
por: Punia, Sohan, et al.
Publicado: (2021)